Evaluation of Risk Factors for Postbooster Omicron COVID-19 Deaths in England. (2022)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1001/jamanetworkopen.2022.33446
PubMed Identifier: 36074469
Publication URI: http://europepmc.org/abstract/MED/36074469
Type: Journal Article/Review
Volume: 5
Parent Publication: JAMA network open
Issue: 9
ISSN: 2574-3805